Layer, Chiang, et al. Genome Biology
Three RNAi, miRNA Firms Record Strong Gains in Stock Value Since the End of 2008
The companies — Rosetta Genomics, MDRNA, and Tekmira Pharmaceuticals — have all seen their shares more than double since Dec. 31, significantly outperforming the Nasdaq Biotechnology Index.
New to GenomeWeb? Register here quickly.